By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


BeiGene Co.,Ltd 

No.30 Science Park Road
Zhong-Guan-Cun Life Science Park
Changping District  Beijing    China
Phone: n/a Fax: n/a



Company News
BeiGene Announces Pricing Of Its Initial Public Offering 2/3/2016 6:19:24 AM
Week In Review: BeiGene Schedules $128 Million IPO For February 1/25/2016 9:39:45 AM
BeiGene Plans $127 Million U.S. IPO In February 1/21/2016 1:34:42 PM
BeiGene Release: U.S. IND Becomes Active For BGB-A317, An Anti-PD-1 Monoclonal Antibody 1/11/2016 8:20:45 AM
BeiGene Selects GE Healthcare’s FlexFactory Biomanufacturing Platform For Pilot cGMP Production Facility In China 12/16/2015 9:43:41 AM
BeiGene Posts Encouraging Early Data On Cancer Drug 12/11/2015 9:31:47 AM
Beigene Presents Clinical Data For BTK Inhibitor BGB-3111 At 57th American Society of Hematology Annual Meeting 12/8/2015 1:57:23 PM
BeiGene Announces Abstract On BGB-3111 To Be Presented At The 2015 American Society of Hematology Annual Meeting 11/23/2015 8:18:45 AM
BeiGene Receives 2015 R&D Achievement Of Year At China Pharmaceutical Awards 11/17/2015 8:07:16 AM
BeiGene Appoints Dr. Zhengming Du As Senior Vice President, Head Of Chemistry And Manufacturing Controls 11/9/2015 9:08:52 AM